"Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations" by Qing Liu

Selected Works of Karl E. Peace

Follow Contact

Article

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations

Qing Liu
Karl E. Peace, Georgia Southern University

Link

Document Type

Article

Publication Date

5-8-2020

Disciplines

Biostatistics,
Environmental Public Health,
Epidemiology and
Public Health

Abstract

Randomization is an essential feature of the clinical trial design (Armitage, 1982). Randomization mitigates potential for experimental bias, promotes comparability of treatment groups, and validates the use of statistical methods for inferential analysis of trial results.

Citation Information

Qing Liu and Karl E. Peace. "Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations" LinkedIn (2020)
Available at: http://works.bepress.com/karl_peace/370/